Annual EBITDA:
-$436.83M+$128.64M(+22.75%)Summary
- As of today, BBIO annual EBITDA is -$436.83 million, with the most recent change of +$128.64 million (+22.75%) on December 31, 2024.
- During the last 3 years, BBIO annual EBITDA has risen by +$97.00 million (+18.17%).
- BBIO annual EBITDA is now -896.89% below its all-time high of -$43.82 million, reached on December 31, 2017.
Performance
BBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$134.96M-$2.80M(-2.12%)Summary
- As of today, BBIO quarterly EBITDA is -$134.96 million, with the most recent change of -$2.80 million (-2.12%) on September 30, 2025.
- Over the past year, BBIO quarterly EBITDA has increased by +$50.63 million (+27.28%).
- BBIO quarterly EBITDA is now -2627.81% below its all-time high of $5.34 million, reached on March 31, 2024.
Performance
BBIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$589.60M+$50.63M(+7.91%)Summary
- As of today, BBIO TTM EBITDA is -$589.60 million, with the most recent change of +$50.63 million (+7.91%) on September 30, 2025.
- Over the past year, BBIO TTM EBITDA has dropped by -$63.20 million (-12.01%).
- BBIO TTM EBITDA is now -1310.12% below its all-time high of -$41.81 million, reached on March 31, 2018.
Performance
BBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BBIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +22.8% | +27.3% | -12.0% |
| 3Y3 Years | +18.2% | -10.2% | -16.2% |
| 5Y5 Years | -56.6% | -12.5% | -82.5% |
BBIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -9.9% | +22.8% | -2627.8% | +38.6% | -36.0% | +13.2% |
| 5Y | 5-Year | -56.6% | +22.8% | -2627.8% | +38.6% | -82.5% | +13.2% |
| All-Time | All-Time | -896.9% | +22.8% | -2627.8% | +38.6% | -1310.1% | +13.2% |
BBIO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$134.96M(-2.1%) | -$589.60M(+7.9%) |
| Jun 2025 | - | -$132.16M(-28.9%) | -$640.23M(+5.7%) |
| Mar 2025 | - | -$102.52M(+53.4%) | -$679.15M(-18.9%) |
| Dec 2024 | -$436.83M(+22.7%) | -$219.97M(-18.5%) | -$571.29M(-8.5%) |
| Sep 2024 | - | -$185.59M(-8.5%) | -$526.40M(-6.0%) |
| Jun 2024 | - | -$171.07M(-3304.2%) | -$496.59M(-6.5%) |
| Mar 2024 | - | $5.34M(+103.0%) | -$466.45M(+21.3%) |
| Dec 2023 | -$565.47M(-42.3%) | -$175.08M(-12.4%) | -$592.95M(-10.3%) |
| Sep 2023 | - | -$155.78M(-10.5%) | -$537.75M(-6.6%) |
| Jun 2023 | - | -$140.93M(-16.3%) | -$504.43M(-16.3%) |
| Mar 2023 | - | -$121.16M(-1.1%) | -$433.69M(+6.1%) |
| Dec 2022 | -$397.44M(+25.5%) | -$119.88M(+2.1%) | -$461.67M(+9.0%) |
| Sep 2022 | - | -$122.45M(-74.4%) | -$507.42M(+5.0%) |
| Jun 2022 | - | -$70.20M(+52.9%) | -$534.20M(+3.8%) |
| Mar 2022 | - | -$149.13M(+10.0%) | -$555.33M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$533.83M(-14.2%) | -$165.64M(-11.0%) | -$572.34M(-7.1%) |
| Sep 2021 | - | -$149.23M(-63.4%) | -$534.19M(-5.8%) |
| Jun 2021 | - | -$91.33M(+45.0%) | -$504.89M(+6.2%) |
| Mar 2021 | - | -$166.14M(-30.3%) | -$538.13M(-44.7%) |
| Dec 2020 | -$467.38M(-67.5%) | -$127.49M(-6.3%) | -$372.00M(-15.1%) |
| Sep 2020 | - | -$119.94M(+3.7%) | -$323.14M(-25.6%) |
| Jun 2020 | - | -$124.57M(-58.4%) | -$257.36M(+3.2%) |
| Dec 2019 | -$278.96M(-67.1%) | -$78.64M(-45.2%) | -$265.75M(-42.0%) |
| Sep 2019 | - | -$54.16M(+21.9%) | -$187.12M(-7.3%) |
| Jun 2019 | - | -$69.32M(-8.9%) | -$174.34M(-24.7%) |
| Mar 2019 | - | -$63.64M(-53.8%) | -$139.76M(-18.5%) |
| Dec 2018 | -$166.90M(-280.9%) | - | - |
| Sep 2018 | - | -$41.38M(-19.1%) | -$117.93M(-54.1%) |
| Jun 2018 | - | -$34.74M(+16.9%) | -$76.55M(-83.1%) |
| Mar 2018 | - | -$41.81M | -$41.81M |
| Dec 2017 | -$43.82M | - | - |
FAQ
- What is BridgeBio Pharma, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual EBITDA year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly EBITDA year-on-year change?
- What is BridgeBio Pharma, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. TTM EBITDA year-on-year change?
What is BridgeBio Pharma, Inc. annual EBITDA?
The current annual EBITDA of BBIO is -$436.83M
What is the all-time high annual EBITDA for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual EBITDA is -$43.82M
What is BridgeBio Pharma, Inc. annual EBITDA year-on-year change?
Over the past year, BBIO annual EBITDA has changed by +$128.64M (+22.75%)
What is BridgeBio Pharma, Inc. quarterly EBITDA?
The current quarterly EBITDA of BBIO is -$134.96M
What is the all-time high quarterly EBITDA for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly EBITDA is $5.34M
What is BridgeBio Pharma, Inc. quarterly EBITDA year-on-year change?
Over the past year, BBIO quarterly EBITDA has changed by +$50.63M (+27.28%)
What is BridgeBio Pharma, Inc. TTM EBITDA?
The current TTM EBITDA of BBIO is -$589.60M
What is the all-time high TTM EBITDA for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high TTM EBITDA is -$41.81M
What is BridgeBio Pharma, Inc. TTM EBITDA year-on-year change?
Over the past year, BBIO TTM EBITDA has changed by -$63.20M (-12.01%)